Swahili
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Bulletin de la Societe belge d'ophtalmologie 1989

[Classical immunosuppressive agents].

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
Kiungo kimehifadhiwa kwenye clipboard
A C Martenet

Maneno muhimu

Kikemikali

Immunodepressive or immunoregulatory drugs might be indicated among the therapeutic possibilities in uveitis and associated diseases, especially in those cases, which resist to specific treatment and steroids, and in those in which disorders of the immune system play a pathogenetic role. Classical cytostatic drugs mainly act by a reduction of the amount of circulating lymphocytes. The most useful seem to be the alkylating drugs (chlorambucil, cyclophosphamide) and antimitotics (procarbazine, colchicine), or antifolic (methotrexate), while the antipurines (azathioprine) seem to us less effective. Such therapy requires the full consent of the patient. The dosage of the drug has to be well established in order to keep the total amount of leucocytes between 4,000-5,000/mm3. Side effects can be hair loss, sterility, rarely hemorrhagic cystitis, and, mostly only in the initial therapy period, nausea and vomiting. Teratogenic risks seem non-existent. Since the therapeutical effect comes rather slowly, a local steroid therapy can be added. Absolute indications for such therapy are Behçet and sympathetic ophthalmitis, while all severe chronic uveitis forms are relative indications. Acute iritis and chorioretinitis are contraindications. The results with procarbazine and cyclophosphamide run around 40% full successes (healing of inflammation and improvement of function) and 30% satisfactory results (healing of inflammatory signs, without improvement of function). Failures amount to 17% and 13% of the patients cannot be thoroughly controlled. With regard to the failures, alternative treatment might be attempted with cyclosporin A, plasmapheresis or perhaps immunostimulation.

Jiunge na ukurasa
wetu wa facebook

Hifadhidata kamili ya mimea ya dawa inayoungwa mkono na sayansi

  • Inafanya kazi katika lugha 55
  • Uponyaji wa mitishamba unaungwa mkono na sayansi
  • Kutambua mimea kwa picha
  • Ramani ya GPS inayoshirikiana
  • Soma machapisho ya kisayansi yanayohusiana na utafutaji wako
  • Tafuta mimea ya dawa na athari zao
  • Panga maslahi yako na fanya tarehe ya utafiti wa habari, majaribio ya kliniki na ruhusu

Andika dalili au ugonjwa na usome juu ya mimea ambayo inaweza kusaidia, chapa mimea na uone magonjwa na dalili ambazo hutumiwa dhidi yake.
* Habari zote zinategemea utafiti wa kisayansi uliochapishwa

Google Play badgeApp Store badge